Gilead Sciences (GILD)

Gilead Sciences (GILD) Financial Statements


Gilead Sciences Financial Overview

Gilead Sciences's market cap is currently ―. The company's EPS TTM is $4.347; its P/E ratio is 17.25; and it has a dividend yield of 3.93%. Gilead Sciences is scheduled to report earnings on October 26, 2023, and the estimated EPS forecast is $1.92. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 6.56B$ 6.31B$ 7.39B$ 7.04B$ 6.26B
Gross Profit$ 5.16B$ 4.95B$ 5.99B$ 5.65B$ 4.82B
EBIT$ 1.82B$ 1.70B$ 2.26B$ 2.66B$ 1.75B
EBITDA$ 2.50B$ 2.34B$ 2.79B$ 3.19B$ 2.27B
Net Income Common Stockholders$ 1.04B$ 1.01B$ 1.64B$ 1.79B$ 1.14B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.67B$ 5.87B$ 6.38B$ 5.66B$ 5.66B
Total Assets$ 62.34B$ 61.88B$ 63.17B$ 62.56B$ 62.87B
Total Debt$ 25.25B$ 25.24B$ 25.23B$ 25.22B$ 26.22B
Net Debt$ 18.58B$ 19.37B$ 18.84B$ 19.56B$ 20.55B
Total Liabilities$ 41.24B$ 40.94B$ 41.96B$ 41.50B$ 42.66B
Stockholders Equity$ 21.16B$ 21.00B$ 21.24B$ 21.08B$ 20.24B
Cash Flow-
Free Cash Flow$ 1.48B$ 1.64B$ 2.39B$ 2.71B$ 1.66B
Operating Cash Flow$ 1.62B$ 1.75B$ 2.57B$ 2.86B$ 1.80B
Investing Cash Flow$ -483.00M$ -826.00M$ -375.00M$ -713.00M$ -308.00M
Financing Cash Flow$ -383.00M$ -1.41B$ -1.55B$ -2.12B$ -1.00B
Currency in USD

Gilead Sciences Earnings and Revenue History

Gilead Sciences Debt to Assets

Gilead Sciences Cash Flow

Gilead Sciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis